85 related articles for article (PubMed ID: 28045490)
1. An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms.
Arencibia JM; Fröhner W; Krupa M; Pastor-Flores D; Merker P; Oellerich T; Neimanis S; Schmithals C; Köberle V; Süß E; Zeuzem S; Stark H; Piiper A; Odadzic D; Schulze JO; Biondi RM
ACS Chem Biol; 2017 Feb; 12(2):564-573. PubMed ID: 28045490
[TBL] [Abstract][Full Text] [Related]
2. Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocket.
Lopez-Garcia LA; Schulze JO; Fröhner W; Zhang H; Süss E; Weber N; Navratil J; Amon S; Hindie V; Zeuzem S; Jørgensen TJ; Alzari PM; Neimanis S; Engel M; Biondi RM
Chem Biol; 2011 Nov; 18(11):1463-73. PubMed ID: 22118680
[TBL] [Abstract][Full Text] [Related]
3. A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells.
Stallings-Mann M; Jamieson L; Regala RP; Weems C; Murray NR; Fields AP
Cancer Res; 2006 Feb; 66(3):1767-74. PubMed ID: 16452237
[TBL] [Abstract][Full Text] [Related]
4. AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases.
Arencibia JM; Pastor-Flores D; Bauer AF; Schulze JO; Biondi RM
Biochim Biophys Acta; 2013 Jul; 1834(7):1302-21. PubMed ID: 23524293
[TBL] [Abstract][Full Text] [Related]
5. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
Fields AP; Frederick LA; Regala RP
Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
[TBL] [Abstract][Full Text] [Related]
6. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanism of regulation of the atypical protein kinase C by N-terminal domains and an allosteric small compound.
Zhang H; Neimanis S; Lopez-Garcia LA; Arencibia JM; Amon S; Stroba A; Zeuzem S; Proschak E; Stark H; Bauer AF; Busschots K; Jørgensen TJ; Engel M; Schulze JO; Biondi RM
Chem Biol; 2014 Jun; 21(6):754-65. PubMed ID: 24836908
[TBL] [Abstract][Full Text] [Related]
8. 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.
Fröhner W; Lopez-Garcia LA; Neimanis S; Weber N; Navratil J; Maurer F; Stroba A; Zhang H; Biondi RM; Engel M
J Med Chem; 2011 Oct; 54(19):6714-23. PubMed ID: 21863889
[TBL] [Abstract][Full Text] [Related]
9. AGC kinases, mechanisms of regulation and innovative drug development.
Leroux AE; Schulze JO; Biondi RM
Semin Cancer Biol; 2018 Feb; 48():1-17. PubMed ID: 28591657
[TBL] [Abstract][Full Text] [Related]
10. Allosteric Regulation of Protein Kinases Downstream of PI3-Kinase Signalling.
Leroux AE; Gross LZF; Sacerdoti M; Biondi RM
Adv Exp Med Biol; 2019; 1163():279-311. PubMed ID: 31707708
[TBL] [Abstract][Full Text] [Related]
11. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the catalytic domain of human atypical protein kinase C-iota reveals interaction mode of phosphorylation site in turn motif.
Messerschmidt A; Macieira S; Velarde M; Bädeker M; Benda C; Jestel A; Brandstetter H; Neuefeind T; Blaesse M
J Mol Biol; 2005 Sep; 352(4):918-31. PubMed ID: 16125198
[TBL] [Abstract][Full Text] [Related]
13. Use of a fluorescent ATP analog to probe the allosteric conformational change in the active site of the protein kinase PDK1.
Hindie V; Lopez-Garcia LA; Biondi RM
Methods Mol Biol; 2012; 928():133-41. PubMed ID: 22956138
[TBL] [Abstract][Full Text] [Related]
14. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
[TBL] [Abstract][Full Text] [Related]
15. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
[TBL] [Abstract][Full Text] [Related]
16. A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1.
Rettenmaier TJ; Sadowsky JD; Thomsen ND; Chen SC; Doak AK; Arkin MR; Wells JA
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18590-5. PubMed ID: 25518860
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein kinase C subtypes in pancreatic cancer.
Storz P
Expert Rev Anticancer Ther; 2015 Apr; 15(4):433-8. PubMed ID: 25604078
[TBL] [Abstract][Full Text] [Related]
18. 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
Stroba A; Schaeffer F; Hindie V; Lopez-Garcia L; Adrian I; Fröhner W; Hartmann RW; Biondi RM; Engel M
J Med Chem; 2009 Aug; 52(15):4683-93. PubMed ID: 19606904
[TBL] [Abstract][Full Text] [Related]
19. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
[TBL] [Abstract][Full Text] [Related]
20. Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer.
Fasano M; Della Corte CM; Califano R; Capuano A; Troiani T; Martinelli E; Ciardiello F; Morgillo F
Expert Opin Investig Drugs; 2014 Jun; 23(6):809-21. PubMed ID: 24673358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
